目的：观察鼻腔内窥镜下泪道支架植入术治疗泪道阻塞的临床疗效。方法回顾性分析山东省滨州市中心医院眼科2010年2月至2011年12月期间采用Fr7、Fr8和Fr9型泪道支架治疗19例（20只眼）泪道阻塞患者的临床资料，在患者泪道和鼻腔黏膜表面...目的：观察鼻腔内窥镜下泪道支架植入术治疗泪道阻塞的临床疗效。方法回顾性分析山东省滨州市中心医院眼科2010年2月至2011年12月期间采用Fr7、Fr8和Fr9型泪道支架治疗19例（20只眼）泪道阻塞患者的临床资料，在患者泪道和鼻腔黏膜表面麻醉下经鼻腔逆行插入泪道支架，治疗泪道阻塞。术前对患者进行泪道造影和泪道冲洗，并确定泪道阻塞的部位，检查确定泪囊的大小，CT检查鼻泪管以确定鼻泪管的骨道粗细。术后1周每日冲洗泪道1次，之后每月冲洗泪道1次。归纳鼻腔内窥镜下泪道支架植入术治疗泪道阻塞的临床疗效。结果本组19例（20只眼）患者，术中均成功植入泪道支架，2只眼于术后3～5 d 发生支架阻塞，经及时冲洗后泪道恢复通畅。术后对患者进行1～13个月的随访，平均10个月，溢泪症状消失、冲洗泪道通畅者19只眼（95％）。溢泪、冲洗欠通畅者1只眼（5％）。结论泪道支架植入术是一种新型治疗泪道阻塞的治疗方法，具有简便、安全和有效的优点。展开更多
AIM:To investigate the feasibility of endoscopic dacryocystorhinostomy(En-DCR)with bicanalicular silicone tube intubation for treating chronic dacryocystitis secondary to nasolacrimal duct stent(NDS)incarceration.METH...AIM:To investigate the feasibility of endoscopic dacryocystorhinostomy(En-DCR)with bicanalicular silicone tube intubation for treating chronic dacryocystitis secondary to nasolacrimal duct stent(NDS)incarceration.METHODS:En-DCRs were performed on 44 chronic dacryocystitis patients(46 eyes)secondary to NDS incarceration from April 2016 to October 2022.The granuloma and scar tissues were separated,and the removal of NDS incarceration was achieved during the surgery;the flap of the lacrimal sac was trimmed and anastomosed with nasal mucosal,a bicanalicular silicone tube was implanted,and lacrimal size and condition were assessed.The tube was removed 3mo after surgery.During the final follow-up of 12mo when the surgery was completed,the complications and the rates of surgical success were assessed.RESULTS:This study covered 40 patients(42 eyes).Intraoperatively,it was found that the lacrimal sac became small,and the sac wall had granulation and scar tissue attached to the incarcerated NDS in all eyes.At 12mo after surgery completed,the rates of the functional and anatomical success reached 80.95%(34/42)and 83.33%(35/42),respectively.Under the effect of intranasal ostial closure,seven eyes failed to achieve anatomical success.No serious complications(e.g.,visual impairment,sinusitis,and orbital fat prolapse)was observed.CONCLUSION:With the success rate over 80%and no serious complications,En-DCR with bicanalicular silicone tube implantation is effective in treating chronic dacryocystitis secondary to NDS incarceration.展开更多
文摘目的：观察鼻腔内窥镜下泪道支架植入术治疗泪道阻塞的临床疗效。方法回顾性分析山东省滨州市中心医院眼科2010年2月至2011年12月期间采用Fr7、Fr8和Fr9型泪道支架治疗19例（20只眼）泪道阻塞患者的临床资料，在患者泪道和鼻腔黏膜表面麻醉下经鼻腔逆行插入泪道支架，治疗泪道阻塞。术前对患者进行泪道造影和泪道冲洗，并确定泪道阻塞的部位，检查确定泪囊的大小，CT检查鼻泪管以确定鼻泪管的骨道粗细。术后1周每日冲洗泪道1次，之后每月冲洗泪道1次。归纳鼻腔内窥镜下泪道支架植入术治疗泪道阻塞的临床疗效。结果本组19例（20只眼）患者，术中均成功植入泪道支架，2只眼于术后3～5 d 发生支架阻塞，经及时冲洗后泪道恢复通畅。术后对患者进行1～13个月的随访，平均10个月，溢泪症状消失、冲洗泪道通畅者19只眼（95％）。溢泪、冲洗欠通畅者1只眼（5％）。结论泪道支架植入术是一种新型治疗泪道阻塞的治疗方法，具有简便、安全和有效的优点。
文摘AIM:To investigate the feasibility of endoscopic dacryocystorhinostomy(En-DCR)with bicanalicular silicone tube intubation for treating chronic dacryocystitis secondary to nasolacrimal duct stent(NDS)incarceration.METHODS:En-DCRs were performed on 44 chronic dacryocystitis patients(46 eyes)secondary to NDS incarceration from April 2016 to October 2022.The granuloma and scar tissues were separated,and the removal of NDS incarceration was achieved during the surgery;the flap of the lacrimal sac was trimmed and anastomosed with nasal mucosal,a bicanalicular silicone tube was implanted,and lacrimal size and condition were assessed.The tube was removed 3mo after surgery.During the final follow-up of 12mo when the surgery was completed,the complications and the rates of surgical success were assessed.RESULTS:This study covered 40 patients(42 eyes).Intraoperatively,it was found that the lacrimal sac became small,and the sac wall had granulation and scar tissue attached to the incarcerated NDS in all eyes.At 12mo after surgery completed,the rates of the functional and anatomical success reached 80.95%(34/42)and 83.33%(35/42),respectively.Under the effect of intranasal ostial closure,seven eyes failed to achieve anatomical success.No serious complications(e.g.,visual impairment,sinusitis,and orbital fat prolapse)was observed.CONCLUSION:With the success rate over 80%and no serious complications,En-DCR with bicanalicular silicone tube implantation is effective in treating chronic dacryocystitis secondary to NDS incarceration.
